Kelly Crowe

Medical science

Kelly Crowe is a medical sciences correspondent for CBC News, specializing in health and biomedical research. She joined CBC in 1991, and has spent 25 years reporting on a wide range of national news and current affairs, with a particular interest in science and medicine.

Latest from Kelly Crowe

Second Opinion

Breaking down the walls of scientific secrecy

A Canadian research team is pushing the boundaries of transparency in biomedical science by publishing their research notes in real time and refusing to patent their discoveries.
Second Opinion

'You disappointed us': Why is Canada opposing more transparency in drug prices?

Frustration at the pharmaceutical industry's high prices and secrecy bubbled over at the World Health Assembly this week as delegates fought for a strongly-worded resolution calling for greater transparency in the cost of clinical trials, drug R&D and prices. But some countries, including Canada, pushed for softer wording that could maintain secrecy in prices and research.
Second Opinion

'Stem cell' therapies offered at private clinics need to be approved as drugs, Health Canada says

Across Canada, private clinics charge thousands of dollars for injections and IV therapies using what they claim are stem cells. This week, Health Canada ruled that those cell therapies are drugs that must be approved. But so far, the agency has not ordered clinics to stop doing the procedures.
Second Opinion

New questions about old Canadian study foreshadowing opioid crisis

How a team of Vancouver inner-city doctors caught early warning signs of looming opioid crisis 20 years ago — research that caught the attention of Purdue Pharma.
Second Opinion

2 young Canadian brothers, a life-threatening disease — and the harsh reality of drug prices

This week's story of two young Canadian brothers with cystic fibrosis reveals a bleak reality — only one has access to a promising new medication in a clinical trial, while a similar drug that could help his brother is too expensive. But access to the manufacturer's drugs is not just a problem in Canada. There are bitter fights in other jurisdictions over how much the company is charging.
Second Opinion

11th-hour lobbying by industry could kill law banning food marketing to kids

It wasn't long ago that all parties supported a federal law to ban food marketing to kids. But a combination of partisan politics and industry lobbying has some fearing the law will die as the clock ticks toward the federal election.
Second Opinion

Cigarettes in plain packages — it only took 25 years

Big tobacco successfully delayed plain packaging laws in Canada for a quarter of a century. But the long awaited public health measure comes into force just as the tobacco industry says its moving beyond cigarettes into a new "smoke-free" future.
Second Opinion

Nova Scotia's health care 'crisis' is Canada's crisis too

Nova Scotia's health-care system came under fire this week when a tearful patient's angry video went viral, blaming the province's doctor shortage for her delayed cancer diagnosis. But it's not just Nova Scotia. The same problems are happening across Canada.
Second Opinion

What happened to triclosan? A lingering legacy of the hyper-hygiene era

A few years ago we were brushing our teeth with it, rinsing our mouths with it, sanitizing our hands with it. And now triclosan is almost vanished from the marketplace.
Second Opinion

A drug to prevent 1 in 5 deaths? It's called 'food'

A new study in The Lancet suggests one in every five deaths globally could potentially be prevented by simply eating better. But population health researchers say much of what we eat is beyond our control.
Second Opinion

'Help!' Health Canada asks Canadians for advice on problem of youth vaping

Health Canada has asked Canadians for 'advice' on ways to prevent vaping from becoming 'normalized among young people.' Meanwhile, one tobacco giant reports an increase in 'poly-usage,' as new vaping products put it 'back in a growth industry.'
Second Opinion

Frozen breaded chicken: the health risk that lurks in your freezer

For years government agencies and industry have told consumers that frozen chicken pieces must be thoroughly cooked, but people kept getting sick. So now there is a rule banning salmonella in frozen breaded chicken products destined for the grocery store.
Second Opinion

Canada's fight with Big Tobacco is back on

Faced with the renewed threat of a multi-billion dollar payout, two of Canada's three largest cigarette companies immediately applied for creditor protection. Meanwhile, the court activity has created a huge cache of company documents that tells a uniquely Canadian version of the tobacco saga.

Biotin, marketed for hair and nails, could skew some medical test results, researchers warn

Biotin, or vitamin B7, is in fashion because of claims it can help people grow better hair and nails. But patients need to be aware that the supplement can interfere with some important lab tests, including those diagnosing heart attacks and thyroid issues, researchers warn.
Second Opinion

Why does it cost millions to access publicly funded research papers? Blame the paywall

There’s a titanic struggle under way over a wall — the paywall that blocks access to much of the world’s scientific literature. Last week, the University of California ended its contract Elsevier, one of the world's most powerful scientific publishing companies. Canadian university librarians cheered.